Pharmaceutical Industry Blog

Last Updated: July 11, 2026 TL;DR: Iran — a nation of more than 92 million people with one of the most developed domestic pharmaceutical industries in the Middle East — produces most of its medicines locally, yet still relies on imports for a significant share of specialised sterile injectables, oncology and biotech products, and a large proportion of its active pharmaceutical ingredients. Every imported sterile injectable must hold an Iran Registration Code (IRC) issued by t

Last Updated: July 11, 2026 TL;DR: Vietnam — a nation of more than 101 million people and one of the fastest-growing pharmaceutical markets in Southeast Asia — depends on a reliable, compliant supply of sterile injectables for its hospitals, its social-health-insurance programme and its provincial procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients. Every imported sterile injectable must

Last Updated: July 10, 2026 TL;DR: The Democratic Republic of the Congo — the fourth-most-populous country in Africa, home to more than 109 million people — depends almost entirely on imported medicines for its hospitals, its essential-medicines network and its large donor-funded health programmes, because domestic production covers only a small fraction of demand. Every imported sterile injectable must hold a marketing authorisation (Autorisation de Mise sur le Marché, AMM)

Last Updated: July 10, 2026 TL;DR: The Philippines — an archipelago of more than 115 million people and one of the fastest-growing pharmaceutical markets in Southeast Asia — depends on a reliable, compliant supply of sterile injectables for its hospitals, its Universal Health Care programme and its government procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients. Every imported sterile inje

Last Updated: July 9, 2026 TL;DR: Mexico — the second-largest pharmaceutical market in Latin America and, with more than 131 million people, one of the largest in the world — depends on a reliable, compliant supply of sterile injectables for its hospitals, its huge public health institutions and its consolidated national tenders, and it imports a significant share of its finished injectables and most of its active ingredients. Every imported sterile injectable must hold a mar

Last Updated: July 9, 2026 TL;DR: Bangladesh — the world's eighth-most-populous country, home to more than 175 million people and one of the most successful pharmaceutical industries in the developing world — meets the overwhelming majority of its own medicine demand from local production and exports finished drugs to well over 100 countries, yet it still imports the great majority of its active pharmaceutical ingredients and the specialised, patented and biologic sterile inj